PT  - JOURNAL ARTICLE
ED  - ,
TI  - Ranitidine v. cimetidine in peptic ulcer
AID  - 10.1136/dtb.20.15.57
DP  - 1982 Jul 23
TA  - Drug and Therapeutics Bulletin
PG  - 57--59
VI  - 20
IP  - 15
4099  - http://dtb.bmj.com/content/20/15/57.short
4100  - http://dtb.bmj.com/content/20/15/57.full
SO  - Drug Ther Bull1982 Jul 23; 20
AB  - For five years cimetidine (Tagamet - SKF) has been the only histamine H2-receptor antagonist available for the treatment of peptic ulceration.1 It has now been joined by ranitidine (Zantac - Glaxo), an H2-receptor antagonist which like cimetidine decreases gastric acid secretion both basal and in response to all stimuli.2, 3 Neither drug affects the H1 receptors in bronchial, vascular or intestinal smooth muscle. Is there anything to choose between them?